Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Paracetamol Stories

2013-05-01 08:30:48

Recent Research Shows Hispanic Community At Risk, New Spanish-language Resources Available WASHINGTON, May 1, 2013 /PRNewswire-USNewswire/ -- Today, the National Alliance for Hispanic Health (the Alliance) announced a partnership with the Acetaminophen Awareness Coalition to increase awareness among Spanish-speaking consumers on the importance of safe use of medicines that contain acetaminophen. Many Hispanic consumers are not aware of any health risks associated with taking too much...

2013-04-29 04:21:08

Adds Essure®, the only non-surgical permanent birth control method, to Bayer's contraception portfolio WAYNE, N.J. and MOUNTAIN VIEW, Calif., April 29, 2013 /PRNewswire/ -- Bayer intends to broaden its portfolio in the field of contraception. Thus, Bayer HealthCare LLC has signed a merger agreement with Conceptus, Inc. (NASDAQ:CPTS), the California-based developer of the Essure(®) procedure, the leading non-surgical permanent birth control method, which is sold in the United...

Get Rid Of That Anxiety With Daily Dose Of Tylenol
2013-04-16 14:13:18

Michael Harper for redOrbit.com — Your Universe Online There are many people who enjoy the work of filmmaker and musician David Lynch. While these people may find his surreal and often very grim and violent themes to be mesmerizing, others could have a very different reaction. His video for the song “Crazy Clown Time,” for example, features no shortage of spinning camera work, violent sounding drums and enough NSFW material to make even the most adventurous feel a slight...

2013-04-16 12:26:32

CHARLESTON, S.C., April 16, 2013 /PRNewswire/ -- Charleston Laboratories, Inc, an emerging specialty pharmaceutical company focused on the research and development of novel pain products that prevent or significantly reduce nausea and vomiting related to opioid analgesics and other pain associated disease states, announced today the U.S. Food and Drug Administration has granted its request for a Pre-IND meeting to discuss the proposed Investigational New Drug, CL-H1T, as a novel treatment for...

2013-04-13 23:03:16

Federal judicial panel consolidates numerous lawsuits alleging liver damage from Tylenol products into a multidistrict litigation in Pennsylvania. Free consultations now available to consumers seeking legal advice over possible side effects. San Diego, CA (PRWEB) April 13, 2013 http://www.resource4thepeople.com/defectivedrugs/acetaminophen.html Resource4thePeople today updates the status of numerous lawsuits alleging links between Tylenol products and liver cancer by announcing that a...

2013-04-08 20:22:20

Diclegis becomes only FDA-approved treatment for "morning sickness" in decades ROSEMONT, Pa., April 8, 2013 /PRNewswire/ -- Duchesnay USA today announced that the Food and Drug Administration (FDA) has granted approval for Diclegis(®) (doxylamine succinate 10mg, pyridoxine hydrochloride 10mg) delayed-release tablets for the treatment of nausea and vomiting of pregnancy (NVP) in women who do not respond to conservative management.(i) It is the only FDA-approved treatment for NVP,...

2013-04-08 08:30:32

Phase 2 Study on Intranasal Oxytocin Therapy for the Treatment of Chronic Migraine Underway MORAGA, Calif., April 8, 2013 /PRNewswire/ -- Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products, today announced that the Instituto de Salud Publica (ISP) of Chile has approved the Company's protocol for its Phase 2 clinical study of TI-001, intranasal oxytocin, for the treatment of chronic...

2013-04-03 08:27:27

Company to explore commercial partnerships for its lead product, Oxycodone DETERx® (COL-003), an abuse-deterrent, extended-release product for chronic pain CANTON, Mass., April 3, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, has hired Douglas Carlson in the newly-created position of Vice President of Business Development. Doug previously held the position of Senior...

2013-04-02 04:21:16

GREENWOOD VILLAGE, Colo., April 2, 2013 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) today announced FDA acceptance of its IND and the treatment of the first fifteen (15) patients in its clinical trial using Ampion(TM) to treat osteoarthritis (OA) of the knee. (Logo: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO) Dr. Vaughan Clift, Ampio's Chief Regulatory Officer noted, "We are grateful to the FDA for suggesting our trial design include a run-in portion to assure...

2013-03-25 08:26:29

LONDON, March 25, 2013 /PRNewswire/ -- GBP25 Million Fundraising for Fast-to-Market Medicines infirst HEALTHCARE, the consumer healthcare company commercialising unique, fast-to-market consumer medicines, today announces it has successfully raised GBP25 million of new funds. The funding, from Invesco Asset Management managed funds, will be used for the launch of the company's medicines into the US$20 billion cough & cold and pain consumer healthcare markets where...